Business
Bio Spectrum
P. D. Hinduja Hospital, King's College London commence first training programme for nurses
P. D. Hinduja Hospital & Medical Research Centre has entered into a strategic services agreement with King's College London, Guy's and St Thomas' NHS Foundation to deliver training in clinical and non-clinical courses for doctors and nurses, research capacity building and executive education to health professionals in India and the UK.
1 min |
BioSpectrum India July 2025
Bio Spectrum
How genomic revolution is reshaping healthcare in emerging markets
A new frontier in medicine, powered by genomics, is unfolding across emerging economies, promising to transform healthcare landscapes from Egypt to China. The application of genomics in healthcare offers a multi-pronged approach to improving public health, from proactive prevention to highly targeted treatments. The benefits are vast and interconnected, creating a powerful ecosystem for medical innovation. Let's explore further.
5 min |
BioSpectrum India July 2025
Bio Spectrum
VFL Sciences partners with Cytosurge AG to bring FluidFM OMNIUM platform to India
Chennai-based VFL Sciences has entered a partnership with Cytosurge AG to offer the FluidFM OMNIUM platform, a semi-automated single-cell manipulation system for non-destructive injection and extraction, compatible with single-cell RNA analysis and advanced gene editing techniques.
1 min |
BioSpectrum India July 2025
Bio Spectrum
How Immune Cell and Gene Therapies are Transforming Treatment in India.
Immune cell and gene therapies are redefining treatment for cancer, genetic disorders, and autoimmune diseases in India. Once considered the realm of science fiction, these living medicines are now at the forefront of clinical care, offering hope for previously untreatable or poorly managed conditions.
4 min |
BioSpectrum India July 2025
Bio Spectrum
Ayush Ministry launches.portal to address issues of adverse drug reaction
In a landmark step toward strengthening consumer protection and regulatory oversight in the field of traditional medicine, the Union Minister of State (Independent Charge), Ministry of Ayush; and Union Minister of State, Ministry of Health & Family Welfare, Government of India, Prataprao Jadhav, recently launched the AyushSuraksha Portal.
1 min |
BioSpectrum India July 2025
Bio Spectrum
"We see India not just as a trade partner, but as a strategic collaborator for the US market and beyond"
Ella Woger-Nieves, Chief Executive Officer of Invest Puerto Rico, spoke BioSpectrum India on the sidelines of BIO 2025, offering insights into how Puerto Rico has firmly positioned itself as the leading pharmaceutical exporter in the United States. With $54.3 billion in annual life sciences exports to over 120 countries, the island is leveraging its strategic location, FDA-aligned manufacturing ecosystem, and robust talent base to attract global biopharma investments. In this interaction, Ella Woger-Nieves discusses Puerto Rico’s infrastructure, policy incentives, global outreach including recent engagements in India, and its long-term vision as a hub for next-generation therapeutics. Edited excerpts;
4 min |
BioSpectrum India July 2025
Bio Spectrum
WHO outlines recommendations to protect infants against RSV
The World Health Organization (WHO) has published its first-ever position paper on immunisation products to protect infants against respiratory syncytial virus (RSV) the leading cause of acute lower respiratory infections in children globally.
1 min |
BioSpectrum India July 2025
Bio Spectrum
Nitika Pharmaceutical strengthens indigenous manufacturing of complex excipients
The Technology Development Board (TDB), Department of Science and Technology (DST), Government of India has extended financial support to Nitika Pharmaceutical Specialties in Nagpur, for their project titled \"Manufacture of Complex Excipients.\"
1 min |
BioSpectrum India July 2025
Bio Spectrum
Sharda Care Healthcity ropes in Dr Chirag Tandon as Director of Internal Medicine
Reinforcing its leadership in comprehensive internal medicine and integrated patient care, Sharda Care Healthcity has appointed renowned physician Dr Chirag Tandon as Director of the Department of Internal Medicine at its state-of-the-art facility in Greater Noida.
1 min |
BioSpectrum India July 2025
Bio Spectrum
Shivtek Spechemi Industries invests Rs 600 Cr to set up new unit in Gujarat
Leading speciality chemicals manufacturer, Shivtek Spechemi Industries, a flagship company of the Shiva Group of Industries, focusing on innovation, sustainability, and high-quality solutions for pharmaceuticals, agrochemicals, and industrial coatings, has announced the finalisation of a new manufacturing facility near Hazira, spread across 1 million+ square feet.
1 min |
BioSpectrum India July 2025
Bio Spectrum
IKP Knowledge Park inks MoU with BITS Pilani Hyderabad to support startups
IKP Knowledge Park had announced the signing of a Memorandum of Understanding (MoU) with BITS Pilani Hyderabad Campus TBI Society (TBIS), a strategic collaboration to strengthen the innovation and technology transfer ecosystem.
1 min |
BioSpectrum India July 2025
Bio Spectrum
Marengo Asia Hospitals strengthens orthopaedic leadership
Marengo Asia Hospitals' flagship unit, Marengo CIMS Hospital in Ahmedabad, has announced the strengthening of their orthopaedic leadership with the onboarding of world-renowned orthopaedic surgeon Dr K. C. Mehta as Director - Orthopaedics and Joint Replacement, Marengo CIMS Hospital, Ahmedabad.
1 min |
BioSpectrum India July 2025
Bio Spectrum
Novo Nordisk Foundation enters into strategic framework agreement with WHO to advance global health
Novo Nordisk Foundation has entered into a strategic framework agreement with the World Health Organization (WHO) to advance global health.
1 min |
BioSpectrum India July 2025
Bio Spectrum
Centre opens investor facilitation portal for traditional medicine sector
The Government of India has launched the Ayush Nivesh Saarthi portal, a dedicated, investor-centric digital platform developed by the Ministry of Ayush in collaboration with Invest India.
1 min |
BioSpectrum India July 2025
Bio Spectrum
Can Indian Companies Compete with MNCs in GLP-1 Production?
With the patents for blockbuster diabetes and obesity drugs, particularly Semaglutide set to expire in India in March 2026, it is expected to trigger a major shift in the market. Indian pharmaceutical companies will be able to launch generic versions of these high-demand GLP-1 receptor agonist drugs. This is a pivotal moment in the offering that will democratise access to expensive therapies that has been till now dominated by multinational companies.
9 min |
BioSpectrum India July 2025
Bio Spectrum
Agenus and Zydus Lifesciences enter $141 M strategic collaboration for biologics manufacturing in US
US-based Agenus Inc., a leader in immuno-oncology innovation, has signed definitive partnership agreements with Ahmedabad based Zydus Lifesciences, including its subsidiaries/ affiliates, designed to accelerate clinical development, scale global manufacturing, and expand patient access to botensilimab and balstilimab (BOT/BAL).
1 min |
BioSpectrum India July 2025
Bio Spectrum
Advancing Affordable Indigenous IMMUNOTHERAPIES
Immunotherapy is transforming modern medicine by offering targeted, effective, and less toxic treatments for cancer, autoimmune disorders, and infectious diseases. As global demand for these therapies grows, India is rapidly positioning itself as a key player in their development and largescale production. We shall take a deep dive into India’s immunotherapy research pipeline—what's driving it, what's holding it back, and whether the country can truly emerge as a global hub for affordable immunotherapy.
10+ min |
BioSpectrum India July 2025
Bio Spectrum
Mapmygenome goes global with acquisition of Microbiome Insights
Hyderabad-based Mapmygenome, an artificial intelligence (AI)driven leader in genomics and personalised health, has announced the strategic acquisition of Microbiome Insights, a global leader in microbial sequencing.
1 min |
BioSpectrum India July 2025
Bio Spectrum
Indian Pharma Exporters Recalibrate Strategies Amid US Drug Price Cuts
US President Donald Trump's recent announcement to cut the cost of prescription drugs has jolted Indian and APAC manufacturers. While this new development comes a few months after the initial pharma tariff move, Indian pharmaceutical companies aren't left with much choice except to strategise their next steps pragmatically. Here we seek some clarity about what stance the Indian manufactures might take to counter such economic bullying tactics of countries like the United States.
8 min |
BioSpectrum India July 2025
Bio Spectrum
Aster DM Healthcare to inject Rs 480 Cr in new facility in Bengaluru
Aster DM Healthcare, one of the largest integrated healthcare providers in India, has announced the signing of a lease agreement to establish its 4th Multispecialty Hospital in Bengaluru.
1 min |
BioSpectrum India July 2025
Bio Spectrum
IDMA names Nikkhil K Masurkar as Vice Chairperson of R&D and Innovation Committee
Nikkhil K Masurkar, Chief Executive Officer of Mumbai-based Entod Pharmaceuticals, has been appointed Vice Chairperson of the R&D and Innovation Committee of the Indian Drug Manufacturers Association (IDMA) for the 20252026 term.
1 min |
BioSpectrum India July 2025
Bio Spectrum
IIT Madras and US researchers study viruses with potential to kill disease-causing bacteria
Researchers at the Indian Institute of Technology Madras (IIT Madras) and US are studying viruses in freshwater lakes.
1 min |
BioSpectrum India July 2025
Bio Spectrum
Vgenomics and Dr. Shroff's Eye Hospital jointly develop unique biomarker to detect Keratoconus
Delhi-NCR based biotech startup Vgenomics has entered into a special partnership with Dr. Shroff's Charity Eye Hospital.
1 min |
BioSpectrum India July 2025
Bio Spectrum
PAG-led Sekhmet Pharma announces appointment of Santosh Mahil as MD & CEO
A private equity consortium led by PAG, a leading Asia-focused investment firm, has announced the appointment of Santosh Kumar Mahil as the Managing Director (MD) and Chief Executive Officer (CEO) of Sekhmet Pharmaventures, an investment platform established to nurture and grow India's next generation of active pharmaceutical ingredient (API) companies.
1 min |
BioSpectrum India July 2025
Bio Spectrum
Qure.ai unveils new AI-powered co-pilot tool for frontline healthcare workers in LMICs
Leveraging its strength in digital health innovation, Mumbai-based startup Qure.ai has launched a new artificial intelligence (AI)-powered co-pilot tool for frontline healthcare workers in resource-constrained geographies.
1 min |
BioSpectrum India July 2025
Bio Spectrum
India-Japan Synergies in CAR-T and ADCs
Cancer remains the leading cause of death globally. As per the World Health Organisation (WHO), there were approximately 9.7 million deaths from cancer in 2022, and around 20 million cancer cases were reported. It is estimated that by 2050, global cancer cases will be around 50 million globally. The rising incidence of cancer has led to a growing focus on individualised and targeted care.
4 min |
BioSpectrum India July 2025
Bio Spectrum
Chandigarh University, UP emerges as new hub for pharmacy education in AI and research
Chandigarh University, Uttar Pradesh (UP) Campus, continues to break new ground in AI-augmented multidisciplinary education with a major milestone- its School of Pharmacy has received formal approval from the Pharmacy Council of India (PCI) for its Bachelor of Pharmacy (B.
1 min |
BioSpectrum India July 2025
Bio Spectrum
Practo appoints Shoumyan Biswas as Global Chief Strategy & Marketing Officer
Practo, India's largest and most trusted health services platform, has announced the appointment of Shoumyan Biswas as its new Global Chief Strategy & Marketing Officer.
1 min |
BioSpectrum India July 2025
Bio Spectrum
IISc develops novel nanozyme to prevent excess blood clotting
Researchers at the Indian Institute of Science (IISc), Bengaluru have developed an artificial metal-based nanozyme that can potentially be used to clamp down on abnormal blood clotting caused by conditions like pulmonary thromboembolism (PTE).
1 min |
BioSpectrum India July 2025
Bio Spectrum
India partners with WHO to mainstream Ayush globally
In a landmark development poised to transform the global standing of traditional medicine systems, an agreement has been signed between the Ministry of Ayush and the World Health Organization (WHO).
1 min |